Search Results 1551-1560 of 18429 for Immunode

1. Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID) - Mayo Clinic

   Seropositive for human immunodeficiency virus (HIV). Seropositive for hepatitis C (except in the setting of a sustained virologic response [SVR], defined as ...

2. Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients with High-Risk Stage III-IV Melanoma that has been Removed by Surgery - Mayo Clinic

   No active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C; patients must have negative testing for HIV, hepatitis ...

3. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   HIV: Subjects with a known human immunodeficiency virus infection. Hypersensitivity: Subjects with a known allergy or intolerance to a monoclonal antibody ...

4. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

   Patients with known infection with human immunodeficiency virus (HIV) are eligible, provided all 3 of the following are true: 1) presence of controlled ...

5. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd for Newly Diagnosed Multiple Myeloma - Mayo Clinic

   * Known history of human immunodeficiency virus (HIV) (HIV 1/2 antibodies) * Administration of strong/moderate CYP3A inhibitors or inducers ≤ 14 days OR 5 ...

6. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

   Is known to have acquired immunodeficiency syndrome. Has current or clinical history of Zollinger-Ellison syndrome or other hypersecretory condition. Has a ...

7. Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

   Known human immunodeficiency virus (HIV) infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months and CD4 T cell ...

8. Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies - Mayo Clinic

   An underlying known disease, a surgical or medical condition that would expose the subject to undue risk; e.g., human immunodeficiency virus (HIV), active ...

9. A Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients with Enteric Hyperoxaluria - Mayo Clinic

   History of or current immunodeficiency disorder including autoimmune disorders and HIV antibody positivity. Hepatitis B surface antigen positivity (subjects ...

10. Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) - Mayo Clinic

    * History of immunodeficiency diseases * Receiving immunosuppressant treatment or on chronic high doses (high-dose therapy exceeding 2 weeks of treatment) ...